Clinical outcomes and characteristics of patients with TP53-mutated acute myeloid leukemia or myelodysplastic syndromes: a single center experience
Mutations in the tumor suppressor gene TP53 are detected in 5-10% of patients with acute myeloid leukemia acute myeloid leukemia: (